Soligenix Announces US Patent Issuance for Use of Dusquetide in Oral Mucositis
Soligenix announced that the United States (US) Patent Office has granted the patent entitled "Novel Peptides and Analogs for Use in the Treatment of Oral Mucositis." The newly issued…
Read More...
Read More...
